€60 million committed to establish AI and robotics in healthcare

The EU project TEF-Health aims to test and validate innovative artificial intelligence (AI) and robotics solutions for the healthcare sector and accelerate their path to market. It is led by Prof. Petra Ritter, who heads the Brain Simulation Section at the Berlin Institute of Health at Charité (BIH) and at the Department of Neurology and Experimental Neurology of Charité – Universitätsmedizin Berlin. The 51 participating project partners from nine European countries will receive funding to the tune of about €60 million , with half coming from the European Commission under its Digital Europe program and half from national funding agencies. Some €2 million of the EC funding will go to the BIH.

Technological advances in the field of AI and robotics are being made at a breathtaking pace – and the healthcare sector is not spared from these developments. Yet it goes without saying that new medical devices and procedures must first prove their safety and usefulness before they can be adopted in clinical practice. In the European Union, the areas of AI and robotics, which are set to have a far-reaching impact on the healthcare sector, especially have to meet high quality requirements, but there is still a lack of testing infrastructure for developing standards, validating innovations, and certifying new products.

This is precisely where the Testing and Experimentation Facility for Health AI and Robotics (TEF-Health) comes in. The new project, supported by the EC and national funding agencies with a total of about €60 million, aims to “facilitate and accelerate the validation and certification of AI and robotics in medical devices,” explains Prof. Petra Ritter, who coordinates the consortium and heads the Brain Simulation Section at the Berlin Institute of Health at Charité (BIH). Some €2 million of the EU funding will go directly to the BIH at Charité. In total, 51 academic and private partners from nine European countries are involved in the project, integrating existing infrastructures as well as building new ones. The project officially kicks off on 1 January 2023.

Putting new technology through the paces

“With TEF Health we mainly want to test novel AI approaches in real-world scenarios,” says Ritter. This includes new software used in areas such as patient care and diagnostics, as well as devices controlled by artificially intelligent programs, some of which are designed for direct use on humans – such as surgical and nursing robots. “We will evaluate how to facilitate market access and acceptance of these smart technologies,” Ritter reports.

The plan is for the project partners to develop new regulatory and ethical requirements, including, for instance, standardized testing protocols and certifications or a specific code of conduct for use of the technology. In addition, the necessary technical and administrative procedures must be developed and created. Also on board the TEF-Health project are therefore leading hospitals, universities, and clinical research institutions such as Sweden’s Karolinska Institutet, as well as state-designated testing organizations such as German safety inspector TÜV and the National Metrology Institute of Germany and its French counterpart, the “Laboratoire national de métrologie et d’essais,” or LNE for short. The newly created evaluation resources and infrastructure will be made available to industry in the future in the form of fee-based services. “Widespread use of these comprehensive testing and evaluation tools will not only accelerate market access for innovative AI and robotics technologies, but will also ultimately boost public confidence in these new developments,” explains Ritter.

Getting to market faster

The TEF-Health project has the express aim of generating and consolidating sustainable collaborations between industry, academic research, and other players. “Long-term partnerships in innovation networks have shown to provide a particularly favorable environment for the transfer of technology from research to practice,” Ritter explains. “What’s more, close cooperation between the various partners avoids duplicating work already done.” This, she says, makes sure investments are used for highest impact. The close collaboration will also help to ensure that going forward research findings are translated more quickly into new products and services. Ultimately, the entire value chain in AI and robotics technologies for healthcare will benefit from this – which in turn will “increase the prosperity and quality of life of society as a whole,” predicts Ritter.

So in the end, TEF-Health will contribute to Digital Europe’s overall aim of increasing the effectiveness, resilience, and sustainability of European health and care systems and reducing healthcare delivery inequalities in Europe, while ensuring compliance with relevant legal, ethical, quality, and interoperability standards and requirements. Or, in Ritter’s words: “With TEF-Health we want to help ensure that the digital transformation of our healthcare system occurs safely and for the benefit of all – as articulated in the BIH’s mission of “turning research into health.”

—————————

About the Berlin Institute of Health at Charité (BIH)
The mission of the Berlin Institute of Health at Charité (BIH) is medical translation: transferring biomedical research findings into novel approaches to personalized prediction, prevention, diagnostics and therapies and, conversely, using clinical observations to develop new research ideas. The aim is to deliver relevant medical benefits to patients and the population at large. As the translational research unit within Charité, the BIH is also committed to establishing a comprehensive translational ecosystem – one that places emphasis on a system-wide understanding of health and disease and that promotes change in the biomedical translational research culture. The BIH was founded in 2013 and is funded 90 percent by the Federal Ministry of Education and Research (BMBF) and 10 percent by the State of Berlin. The founding institutions, Charité – Universitätsmedizin Berlin and the Max Delbrück Center, were independent member entities within the BIH until 2020. Since 2021 the BIH has been integrated into Charité as its so-called third pillar. The Max Delbrück Center is now the Privileged Partner of the BIH.

Contact
Dr. Stefanie Seltmann
Head of Communications and Press Spokesperson
Berlin Institute of Health at Charité (BIH)

+49 (0)30 450 543019
stefanie.seltmann@bih-charite.de

Wissenschaftliche Ansprechpartner:

Professor Petra Ritter, Head of Brain Simulation Section at Berlin Institute of Health at Charité (BIH)

http://www.bihealth.org